Andere Sprachen Cannara Biotech Inc.

Aktien

A3D495

CA13765U2002

LOVE

Markt geschlossen - Toronto S.E. Andere Börsenplätze 18:50:35 22.05.2024			% 5 Tage	% 1. Jan.
0,8 ^CAD	-1,23 %		+3,90 %	-3,61 %

29.04.	Cannara Biotech dreht ins Minus und meldet einen größeren Nettoverlust im 2. Quartal gegenüber dem Vorjahr, trotz eines Umsatzanstiegs von 51%	MT
29.04.	Cannara Biotech Inc. meldet Ergebnis für das zweite Quartal und die sechs Monate bis zum 29. Februar 2024	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Cannara Biotech Turns Negative As Reports Wider Q2 Net Loss Vs a Year Ago, Despite Revenue up 51%	29.04.
Cannara Biotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 29, 2024	29.04.
Cannara Biotech Reports Q2 2024 Financial Results	29.04.
Cannara Biotech CFO Nicholas Sosiak: Unveiling Success Strategies and Future Plans	08.02.
Cannara Biotech Inc. Reports Earnings Results for the First Quarter Ended November 30, 2023	29.01.
Cannara Biotech to Host Investor Webcast on Thursday December 14th, 2023	11.12.
Cannara Biotech Inc. Reports Earnings Results for the Full Year Ended August 31, 2023	07.12.
Cannara Biotech's Fiscal Q4 Profit, Revenue Grows; Up 9.4%	07.12.
Cannara Biotech Inc. Reports Earnings Results for the Fourth Quarter Ended August 31, 2023	07.12.
Tranche Update on Cannara Biotech Inc.'s Equity Buyback Plan announced on November 30, 2022.	27.07.23
Cannara Biotech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended May 31, 2023	27.07.23
Cannara Biotech Inc. Reports Record Q3 2023 Financial Results with Net Revenues of $15.9 Million and Net Income of $2.9 million	27.07.23
Cannara Biotech Inc Announces Participation in the LD Micro Invitational XIII	23.05.23
Tranche Update on Cannara Biotech Inc.'s Equity Buyback Plan announced on November 30, 2022.	24.04.23
Cannara Biotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 28, 2023	24.04.23
Cannara Biotech Down Near 8% As Enters into an Automatic Share Purchase Plan	28.02.23
Cannara Biotech Inc. Enters into an Automatic Share Purchase Plan	28.02.23
Cannara biotech inc. Announces results of annual shareholder meeting and conversion into equity of a $5m convertible debenture at $0.18 cent per common share	13.02.23
Cannara Biotech Converts CA$5 Million Debenture, Plus Interest, into Nearly 30 Million Shares for Olymbec Investments	10.02.23
Tranche Update on Cannara Biotech Inc.'s Equity Buyback Plan announced on November 30, 2022.	23.01.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Cannara Biotech Inc.

Aktien

A3D495

CA13765U2002

LOVE

Andere Sprachen

Filter